Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03290534 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT03290534 · ClinicalTrials.gov record · last posted 2025-04-04

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

Name: Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet® — clinical trial record (NCT03290534)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorCivaTech Oncology

Started2019-03-13

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical structures, such as the heart wall, while giving a therapeutic dose to diseased tissue, such as at a surgical margin.

Amendment record 9 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 9 times since 2017-09-20; most recent amendment 2025-04-02. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2019-06-04

Status change Not Yet Recruiting→Recruitingv3

Trial Details

NCT Number	NCT03290534
Lead Sponsor	CivaTech Oncology
Conditions	Lung Cancer, Lung Cancer Stage I, Lung Cancer Stage II
Enrollment	40 participants
Start Date	2019-03-13
Primary Completion	2026-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-04-04